HI
DPLO

HBK Investments’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

HBK Investments’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,812
Closed -$258K – 1226
2018
Q1 		$258K Buy
+12,812
New +$299K ﹤0.01% 884

Other funds holding DPLO

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

HBK Investments's DPLO Position: Q2 2018 in Review

HBK Investments sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 12,812 shares — an estimated $258K sold.

HBK Investments first reported a position in DPLO in Q1 2018 and held it in 1 quarter. The position peaked at $258K in Q1 2018. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

  • HBK Investments reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
  • HBK Investments sold 12,812 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $258K.
  • HBK Investments first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2018 and held it in 1 quarter.
  • HBK Investments's DIPLOMAT PHARMACY, INC. position peaked at $258K in Q1 2018.
  • 206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on HBK Investments's 13F filing for Q2 2018, filed 14 Aug 2018.